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Summary
 
Hematopoietic stem cells (HSCs) in adult marrow are believed to be derived from fetal liver
precursors. To study cell kinetics involved in long-term hematopoiesis, we studied single-
sorted candidate HSCs from fetal liver that were cultured in the presence of a mixture of stim-
ulatory cytokines. After 8–10 d, the number of cells in primary cultures varied from 
 
,
 
100 to
 
.
 
10,000 cells. Single cells in slow growing colonies were recloned upon reaching a 100–200
cell stage. Strikingly, the number of cells in subclones varied widely again. These results are in-
dicative of asymmetric divisions in primitive hematopoietic cells in which proliferative poten-
tial and cell cycle properties are unevenly distributed among daughter cells. The continuous
generation of functional heterogeneity among the clonal progeny of HSCs is in support of in-
trinsic control of stem cell fate and provides a model for the long-term maintenance of hemato-
poiesis in vitro and in vivo.
Key words: asymmetric cell divisions • stem cells • hematopoiesis • cell cycle • long-term 
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B
 
lood formation originates in a small population of he-
matopoietic stem cells (HSCs)
 
1
 
 that have been defined
as pluripotent cells with self-renewal capacity (1, 2). The
mechanisms underlying the proliferation and differentiation
of HSCs are incompletely understood (3, 4). Both extrinsic
(e.g., growth factors and cell–matrix interactions) and in-
trinsic factors (e.g., developmentally controlled transcrip-
tion factors) are involved in the regulation of HSCs. Al-
though hematopoietic growth factors and an adequate
microenvironment are crucial for the survival and prolifera-
tion of HSCs, self-renewal/differentiation decisions in HSCs
seem to be derived largely independently of cytokines and
are postulated to be determined intrinsically (4–8).
Studies aimed at dissecting the molecular mechanism in-
volved in stem cell regulation have been hampered by diffi-
culties in obtaining populations of HSCs devoid of more
differentiated progenitor cells. Apart from a paucity of dis-
tinguishing phenotypic features, these difficulties are also
related to available HSCs assays. Thus, despite intense ef-
forts to establish determinants by which primitive HSCs
can be defined prospectively, available in vivo and in vitro
stem cell assays only allow retrospective identification of
HSCs. In mice, candidate HSCs are believed to be among
the cells expressing a Thy-1.1
 
lo
 
Sca1
 
hi
 
Lin
 
2
 
/lo
 
 phenotype (9,
10). This cell population represents 
 
,
 
0.1% of murine fetal
liver and is highly enriched for multipotent progenitors
(11). However, cells with this phenotype display consider-
able heterogeneity with respect to “stem cell” properties
such as CFU-S formation (12), and only a minority has the
ability to reconstitute lympho-myelopoiesis in lethally irra-
diated recipients (10, 13). In the last two decades, a large
amount of effort has also been directed towards the devel-
opment of in vitro assays for human HSCs (for review see
reference 14). One prominent example of such an assay is
the long-term culture–initiating cell (LTC-IC) assay (15).
LTC-ICs are hematopoietic cells that are capable of gener-
ating myeloid colony-forming cells after at least 5 wk of
culture in the presence of irradiated feeder cells. LTC-ICs
are highly enriched among cells with a CD34
 
1
 
CD38
 
2
 
 
 
phe-
notype, and the yield of LTC-ICs in such cells from adult
human marrow and umbilical cord blood is 
 
z
 
20 (16) and
 
z
 
50% (17), respectively. Based on these considerations, hu-
man CD34
 
1
 
CD38
 
2
 
 
 
cells are expected to be highly enriched
for HSCs. However, the frequency of CD34
 
1
 
CD38
 
2
 
 cord
 
1
 
Abbreviations used in this paper: 
 
HSC, hematopoietic stem cells; LTC-IC,
long-term culture–initiating cell.
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blood cells capable of initiating hematopoiesis in immune
deficient mice is only 0.1% (18–20). The heterogeneity
within the CD34
 
1
 
CD38
 
2
 
 
 
compartment of human cells is
reminiscent of the functional heterogeneity as outlined
above for murine cells with a Thy-1.1
 
lo
 
Sca1
 
hi
 
Lin
 
2
 
/lo
 
 phe-
notype.
To study the functional heterogeneity of candidate HSCs,
we followed the fate of single-sorted fetal liver CD34
 
1
 
CD38
 
2
 
cells
 
 
 
that were cultured in cytokine-supplemented serum-
free medium. By combining observations on in vitro growth
with a detailed characterization of individual cells produced
in culture, we observed that functional heterogeneity is
continuously generated among the clonal progeny of HSCs.
Furthermore, the growth characteristics of cell clones allowed
us to more closely and, to a certain degree, semiprospec-
tively define cells with the highest proliferative capacity.
Our observations provide an explanation for the extreme
functional heterogeneity among highly purified candidate
HSCs. Several possible mechanisms for the asymmetric cell
divisions that best explain our findings are discussed.
 
Materials and Methods
 
Purification of Fetal Liver Stem Cell Candidates
 
Cells with CD34
 
1
 
CD38
 
2
 
CD71
 
2
 
CD45RA
 
2
 
 
 
phenotype were
isolated from previously frozen samples of fetal liver obtained
from elective, therapeutic abortions in wk 10–16 of gestation.
The use of human material was approved by local Institutional
Review Boards as well as the Ethical Screening Committee of the
University of British Columbia. Cells were separated using Fi-
coll-Hypaque and processed for flow cytometry cell sorting as
previously described (6, 21). In brief, cells were labeled with
OKT-9–FITC (anti-CD71), 8G12-Cy-5 (anti-CD34), 8d2-PE
(anti-CD45RA), and Leu-17–PE (anti-CD38; Becton Dickin-
son, San Jose, CA) and sorted using a dual laser FACStar
 
Ò
 
 Plus
(Becton Dickinson) equipped with an argon and helium-neon
laser (Fig. 1). Cells either were collected in serum-free medium
or were individually sorted directly into round-bottomed tissue
culture plates (Nunc, Roskilde, Denmark) containing serum-free
medium supplemented with hematopoietic growth factors (as in-
dicated below) using an automatic cell deposition unit (Becton
Dickinson). The experimental design of the culture experiments
is shown in Fig. 2.
 
Culture of Cells
 
Single-cell Cultures.
 
Single-sorted cells were cultured in 96-
well round-bottomed plates (60 cells/plate) with each well con-
taining 100 
 
m
 
l of serum-free medium (21) containing 100 ng/ml
each of Steel factor (or stem cell factor) and Flt-3 ligand and 20
ng/ml each of IL-3, IL-6, and G-CSF. After 5–7 d of culture, an-
other 100 
 
m
 
l of growth factor–containing medium was added.
After 6–9 d, the number of cells per well varied over a wide range
from wells with 
 
.
 
10,000 cells to wells with 
 
,
 
100 cells. Slowly
growing colonies with 100–250 cells after 8–13 d in culture were
recloned and the number and morphology (shape, size, and re-
fractive index) of cells in each subclone were scored at various
time intervals. Slowly growing colonies were recloned again be-
tween days 8 and 19. Such recloning of subclones was repeated
until the sixth generation.
 
Expansion Culture.
 
For the evaluation of the proliferative po-
tential slow growing colonies that had reached a level of 5 
 
3 
 
10
 
4
 
 cells
were transferred in 1-ml cultures of 24-well plates. CD34
 
1
 
CD38
 
2
 
cells were resorted every 5–10 d as described above if cultures be-
came confluent (
 
.
 
10
 
6
 
 cells/well) to initiate subcultures until the
percentage of CD34
 
1
 
CD38
 
2
 
 cells per well dropped below 0.1%
of viable cells.
 
Results
 
Characterization of Primary Cultures Derived from Single
CD34
 
1
 
CD38
 
2
 
 
 
Fetal Liver Cells.
 
Single CD34
 
1
 
CD38
 
2
 
 fe-
tal liver stem cell candidates were sorted in individual wells
of microtiter plates containing serum-free medium supple-
mented with cytokines (see Materials and Methods). The
plating efficiency (number of wells containing visible single
cells after sorting) was 
 
.
 
90%, of which 
 
.
 
80% appeared vi-
able after 24 h. The cell number, morphology, and the per-
centage of CD34
 
1
 
CD38
 
2
 
 cells in primary clones was ana-
lyzed at different time intervals. After 6–9 d, the number of
cells in the cultures varied over a wide range, indicating ex-
tensive heterogeneity among fetal liver CD34
 
1
 
CD38
 
2
 
cells. Rapidly growing clones of 
 
.
 
10,000 cells as well as
Figure 1. FACSÒ profile of the CD341CD382 candidate HSCs sorted
from fetal liver to initiate single cell cultures in 96-well plates. Viable,
propidium iodide negative (PI2) CD341CD382 cells with a low side
scatter (SSC) and low levels of CD45RA and CD71 expression were re-
covered from the indicated sort windows. Figure 2. Experimental design of study. 
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slow growing clones of 
 
,
 
50 cells were observed. All wells
with growing cells (
 
n
 
 5 
 
121) were transferred to 1-ml cul-
tures after 5 
 
3 
 
10
 
4
 
 or more cells were present between 10
and 21 d of culture. Cells with a CD34
 
1
 
CD38
 
2
 
 
 
phenotype
were resorted from expanded 1-ml cultures when these
cultures became confluent (0.5-2.0 
 
3 
 
10
 
6
 
 cells) and used
for continuation of cultures using identical culture condi-
tions. This procedure was repeated until no more CD34
 
1
 
cells were produced. Three different categories (A–C) were
defined based on the ability to produce CD34
 
1
 
CD38
 
2
 
 
 
cells
in culture. Clones producing CD34
 
1
 
CD38
 
2
 
 cells up to
day 16 were categorized as A, whereas colonies producing
CD34
 
1
 
CD38
 
2
 
 cells for up to day 59 or more were catego-
rized as B and C, respectively.
Retrospective analysis revealed that colonies that gave
rise to the highest number of CD34
 
1
 
CD38
 
2
 
 cells for the
longest time period corresponded to primary clones with
slow growth properties in the first 9 d of culture (Table 1).
This fraction represented 16% of the clones analyzed,
whereas the majority of clones (60%) were fast growing
(
 
.
 
10
 
3
 
 cells at day 9) with a relatively low expansion poten-
tial. Furthermore, the number of cells in fast growing colo-
nies already started to plateau at day 10, whereas the cell
number in slow growing clones was still expanding at day 12
(Fig. 3). These observations underscore the functional het-
erogeneity of the CD34
 
1
 
CD38
 
2
 
 cell compartment in hu-
man fetal liver and suggest that categories A and B repre-
sent the property of more differentiated progenitor cells.
 
Expansion Potential of Single-sorted CD34
 
1
 
CD38
 
2
 
 Fetal
Liver Cells.
 
To further characterize the expansion potential
of slow growing clones, the experiment described above
was repeated with CD34
 
1
 
CD38
 
2
 
 cells from a different fe-
tal liver. The CD34
 
1
 
CD38
 
2
 
 expansion potential per clone
varied over a wide range, from 1.43 
 
3 
 
10
 
4
 
 to 2.7 
 
3 
 
10
 
12
 
,
with an average expansion of 8.65 
 
3 
 
10
 
8
 
 CD34
 
1
 
CD38
 
2 cells
in the 27 clones that were analyzed. The maximum contin-
ued production of CD341CD382 cells was 129 d. Strik-
ingly, a single clone produced 2.7 3 1012 CD341CD382
cells over 106 d in culture (corresponding to at least 41
“self-renewal” population doublings). Interestingly, in this
clone (Fig. 4), the calculated average cell cycle time of
CD341CD382 cells in culture was very long up to day 15
(70.2 h), decreased from day 29 to 57 (to 43.3 h), and fi-
nally gradually increased again up until day 117 (72.4 h).
These findings indicate that after an initial period of slow
growth, the CD341CD382 cells divided more rapidly be-
fore decreased turnover and eventual loss of CD341CD382
cell production. Similar growth kinetics were observed for
the other clones with lower proliferative potential exam-
ined in these experiments.
In general, these results document that extensive hetero-
geneity exists in the ability to produce CD341CD382 cells
among slow growing CD341CD382 fetal liver cells. To
examine whether the early proliferative response of single
slow growing clones is a good predictor of maximum ex-
pansion potential, the cell numbers in clones at different
time intervals were plotted against the total number of
CD341CD382 cells produced by that clone. Linear regres-
sion analysis revealed a significant negative correlation (P 5
0.0006) between the cell number at day 6 and the maxi-
mum CD341382 expansion potential (Fig. 5). This result
Table 1. Production of CD341CD382 Cells by Single Cells in Serum-free Medium Supplemented with Steel Factor, Flt-3, IL-3, IL-6,
and G-CSF
Category
Production of CD341CD382
cells up to day
No. of clones
(n 5 121) Proportion (%)
Maximum CD341CD382
expansion*
Average cell-cycle 
time (h) up to day 9‡
A 16 73 60 4.4 3 103 20.8 6 0.2
B 59 29 24 6.6 3 107 24.8 6 0.1
C 129 19 16 2.7 3 1012 32.0 6 0.1
*Obtained by repeated sorting and reculture of CD341CD382 cells in 1-ml cultures until no more CD341CD382 cells were produced.
‡Obtained by dividing the culture period in hours by the log2 of the estimated number of cells (n) at day 9.
Figure 3. Clonal heterogeneity in early proliferative response of single-
sorted CD341CD382 fetal liver cells cultured in growth factor–supple-
mented SFM. Single CD341CD382 fetal liver cells were sorted into the
wells of round-bottomed microtiter plates containing serum-free medium
supplemented with Steel factor, Flt-3 ligand, IL-3, IL-6, and G-CSF at
378C. At the indicated time intervals, the number of cells in each well was
scored.1120 Asymmetric Divisions in Hematopoietic Stem Cells
suggests that the proliferative potential and cell cycle char-
acteristics in primitive hematopoietic cells are linked.
Heterogeneity in Subclones Derived from Slow Growing
CD341CD382  Fetal Liver Clones. To further analyze the
functional heterogeneity within the most primitive, slow
growing CD341CD382 fetal liver cells, we recloned cells
recovered from category C at days 8–19, when cell num-
bers had reached between 100 and 250 cells. Individual
subclones were analyzed with respect to cell number and
morphology at different time intervals and, in some cases, also
analyzed for total CD341CD382 cell production as described
above for primary clones. Surprisingly, the clonal heteroge-
neity observed in the primary single-sorted CD341CD382
fetal liver cells was preserved. This is shown for five con-
secutive generations of subclones of a single slow growing
colony of CD341CD382 cells in Fig. 6. Furthermore, as
shown in Fig. 7, the distribution pattern of the three cate-
gories remained more or less constant through multiple
generations of recloning, with fast growing clones repre-
Figure 4. Expansion potential and average cell cycle time of
CD341CD382 cells resorted from expanded cultures initiated with a sin-
gle-sorted CD341382 fetal liver cell. Initial culture and subculture of the
CD341CD382 cells was in serum-free media supplemented with cyto-
kines. The average cell cycle time of CD341CD382 was calculated as de-
scribed in Table 1.
Figure 5. Correlation between early proliferative response at day 6 of
slow growing clones derived from single-sorted CD341CD382 fetal liver
cells and maximum CD341382 expansion potential of different clones.
The maximum expansion potential was determined by repeated subcul-
ture of CD341CD382 cells sorted from confluent 1-ml cultures initially
seeded with the content of a single well. *Estimated cell numbers: amount
of CD341382 was not determined due to low cell numbers; expansion
was calculated on total cells for these clones.
Figure 6. Clonal heterogene-
ity of subclones is preserved
through at least five consecutive
generations of recloning of slow
growing clones derived from sin-
gle-sorted CD341CD382 fetal
liver cells. The average number
of cells in multiple clones of cat-
egories A, B, and C (see text) is
plotted. A single “category C”
clone (dotted line and *) was re-
cloned when 100–200 cells were
present and this was repeated for
subsequent category C sub-
clones that were produced from
a single initial clone.1121 Brummendorf et al.
senting the majority. Slowly growing clones that did not
show morphological features of terminal (macrophage) dif-
ferentiation represented 20% of primary clones and be-
tween 20 and 30% of second to fourth generation sub-
clones, and decreased to ,10% by the sixth generation (Fig.
7). Our results indicate that the number of CD341CD382
cells with extensive replating potential in slow growing
clones decreases upon multiple rounds of recloning.
Compared with the findings in slow growing clones, re-
cloning of intermediate or fast growing clones revealed a
more homogeneous growth pattern in subclones. In such
subclones, the vast majority (.90%) either developed into
mature macrophages or produced up to a few thousand
CD341CD382 cells over 2–3 wk before terminal myeloid
differentiation.
Discussion
The data presented in this paper provide insight into
three major aspects of stem cell biology. First, the data
show that CD341CD382 candidate HSCs from fetal liver
display extensive functional heterogeneity when cultured as
single cells in defined culture conditions. Secondly, this
heterogeneity is generated in the slow growing progeny of
single-sorted fetal liver cells. Thirdly, cells with the highest
overall proliferative potential could be recognized by their
slow growth kinetics, allowing early identification of colo-
nies containing cells with a very high proliferative poten-
tial.
The majority of subclones derived from slow growing
CD341CD382 cells were fast growing clones with a low
proliferative potential. However, a minority of subclones
showed similar growth kinetics to the parental clones, and
this heterogeneity was preserved through four to six gener-
ations of recloning. Because culture conditions were kept
constant in all these experiments, our findings support the
conclusion that differences in the fate of individual stem
cells are continuously and intrinsically generated. What
could be the mechanisms involved in the heritable func-
tional heterogeneity within the clonal progeny of slow
growing candidate HSCs? The most simple hypothesis is
that daughter cells are endowed with different cell fates via
asymmetric cell divisions (Fig. 8). Such asymmetric cell di-
visions would result in one daughter cell being similar to
the mother cell and the other daughter cell more commit-
ted to terminal differentiation. Alternatively, differences in
cell fate could be acquired after mitosis by unknown mech-
anisms. Direct evidence for asymmetric divisions in early
Figure 7. Percentage of slow, intermediate, and fast growing clones in
the progeny of single-sorted CD341CD382 fetal liver cells shown in Fig.
6. n 5 number of clones/generation. Figure represents pooled data from
two experiments.
Figure 8. The intrinsic timetable model of stem cell biology. In this
model, the functional properties of stem cells are (i) linked to the number
of preceding cell divisions or generations (g) and (ii) unevenly distributed
among daughter cells upon each cell division. It is postulated that each
stem cell division is asymmetric and results in daughter cells that differ in
cell cycle properties. As a result, the time interval between successive gen-
erations (t 1, t 2, etc.) is variable between clones of the same generation
and the interval between divisions is subject to both intrinsic (develop-
mental) and extrinsic (microenvironment and growth factors) control.
Clonal variations in turn-over time result in an extreme hierarchy of stem
cells varying in replicative history and related functional properties that is
difficult to reconcile with the concept of stem cells as a homogeneous
population of cells.
Figure 9. Possible mechanisms of asymmetric cell division in HSCs.1122 Asymmetric Divisions in Hematopoietic Stem Cells
hematopoiesis was previously reported using time lapse video
recordings of CD341CD71loCD45RAlo bone marrow pro-
genitor cells in culture (22). In our study, we also observed
a distinct polarity among slow growing CD341CD382 cells:
such cells were small, motile, and appeared as “commas”
with most of the cellular volume preceding a cytoplasmic tail
of one to two cell diameter (5–10 mm). In previous studies,
it was reported that z20% of the cell divisions in early he-
matopoiesis would qualify as asymmetric (5, 6), whereas
extensive amplification of cell numbers during proliferation
and expansion of more committed hematopoietic progeni-
tors would involve primarily symmetric divisions (3).
To date, limited data on the mechanism involved in asym-
metric division of HSCs are available. Investigations of asym-
metric division in plants (for review see reference 23), Caeno-
rhabditis elegans (24), Drosophila and other species (for review
see reference 25), as well as in mammalian neural stem cells
(26–28) have elucidated several distinct possibilities, and sev-
eral working models based on these better defined systems
are shown in Fig. 9. Similar mechanisms are implicated in
asymmetric cell divisions in Drosophila and mammalian neu-
ral progenitor cells (for review see references 29, 30). Many
different proteins involved in these processes have been
identified, some of which, i.e., the notch- (27) and numb-
(28) families of proteins, may also be involved in early
hemopoiesis (Fig. 9 a). Indeed, Drosophila neuroblast stem
cells have been shown to undergo self-renewing asymmetric
divisions in culture (31), very similar to the data on fetal liver
HSCs reported here. Recently, Milner et al. showed that
constitutive expression of the intracellular domain of notch-1
in the 32D myeloid progenitor cell line leads to inhibition of
differentiation and to expansion of undifferentiated cells in
response to G-CSF (32). These effects have recently been
shown to be transmitted by the Notch-1-ligand Jagged-1
(33). The pros gene, which encodes for the homeodomain-
containing nuclear protein prospero, is involved in asymmet-
ric divisions of Drosophila neuroblasts (Fig. 9 c and refer-
ences 34, 35). This might be of special interest in light of
recent data on the role of homeobox transcription factors
HOXA10 (36), HOXB4 (37), and others in hematopoiesis
(38, 39). Studies on oligodendrocyte precursor cells by Gao
and Raff (26) also resemble the observations reported here.
Gao and Raff concluded that the differentiation and matura-
tion of oligodendrocyte precursor cells is an intrinsic prop-
erty of the cell and that asymmetric divisions of precursors
contribute to differences in cell fate. Interestingly, the cell
cycle time of different precursors was also found to be related
to cell fate in their studies. Finally, it also seems important to
exclude asymmetric inheritance of extrachromosomal rDNA
circles (40) as an explanation for the divergence in the fate of
HSCs (Fig. 9 d).
It is tempting to speculate that our observations provide
an explanation for the recent observation that committed
progenitor cells do not mediate early hematopoietic recon-
stitution after blood cell transplantation in mice (41). Ac-
cording to this scenario, slow growing clones, capable of
engrafting lethally irradiated recipients, would produce rap-
idly growing and differentiating subclones while simulta-
neously producing more primitive precursors. Data on on-
togeny-related changes in the functional properties and
telomere length of fetal liver compared with cord blood
and adult bone marrow cells (42, 43) have led to the specu-
lation that the replicative life span of phenotypically identi-
cal HSCs may decrease with age and could be limited to
,100 cell divisions (4). A model of early stem cell biology
that is compatible with both asymmetric divisions of the
HSCs and ontogeny-related changes in HSC function is
shown in Fig. 8.
In conclusion, the data shown here provide further evi-
dence that the fate of the most primitive HSC is primarily
determined intrinsically and regulated only in a permissive
way by extrinsic factors in agreement with previous studies
in model systems (8, for review see reference 44). The
mechanisms underlying the asymmetric divisions of HSCs
documented here appear to be a fruitful area for further
studies.
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